Browsing Tag
10x Genomics
7 posts
10x Genomics (TXG) just made its biggest spatial biology bet yet, can Atera change the rules?
10x Genomics has launched Atera to scale whole-transcriptome spatial biology. Read what this means for TXG, competitors, and translational research.
Is 10x Genomics (Nasdaq: TXG) building the next TCGA for Asia? Inside the ASTRA atlas project
Discover how ASTRA and 10x Genomics are building a spatial cancer atlas to transform precision oncology in Asia-Pacific. Learn what’s driving this shift.
From 10X Genomics to Takara Bio: what LatchBio’s massive spatial atlas means for biotech
LatchBio releases a 25 million cell spatial atlas spanning 11 platforms and 63 diseases. Discover how this AI-ready data is transforming spatial biology.
KROMATID secures $8m Series C funding to accelerate genomic structural analysis and gene therapy partnerships
KROMATID raises $8M Series C to expand genomic structural analysis and gene therapy partnerships. Find out how this growth could reshape biotech.
Can 10x Genomics’ Xenium Protein rewrite the rules of multiomics while Scale Biosciences boosts single cell reach?
10x Genomics launches Xenium Protein and acquires Scale Biosciences, reshaping spatial and single cell biology. See how this impacts research and investors.
10x Genomics introduces new solutions for single cell and spatial biology research
10x Genomics, Inc. (Nasdaq: TXG), a pioneering company in single cell and spatial biology, has announced the commercial…
10x Genomics unveils first products with advanced GEM-X technology
In a significant advancement for the field of single cell and spatial biology, 10x Genomics, Inc. (Nasdaq: TXG)…